The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.
Xiaoqi LiuZhongrong YangJing LiZhenqian WuXiaoqi LiuHui WangYuxin ChenZiyi WangZhaowei TongXiaofeng LiFeilin RenMeihua JinGuangyun MaoPublished in: PloS one (2024)
The prevalence of dyslipidemia varies according to different antiretroviral regimens. Using both horizontal and longitudinal data, we have repeatedly demonstrated that AZT has a more adverse effect on blood lipids than TDF from two perspectives. Therefore, we recommend caution in using the 3TC+EFV+AZT regimen for people at clinical risk of co-occurring cardiovascular disease.
Keyphrases
- hiv infected
- cardiovascular disease
- human immunodeficiency virus
- hiv aids
- hiv positive
- hiv infected patients
- antiretroviral therapy
- risk factors
- electronic health record
- men who have sex with men
- big data
- type diabetes
- hepatitis c virus
- emergency department
- south africa
- fatty acid
- adverse drug
- metabolic syndrome
- artificial intelligence